Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1081 | 1081 | 1111 | 1331 | 1613 | 3034 |
Fund Return | 8.14% | 8.14% | 11.12% | 10.01% | 10.04% | 11.74% |
Place in category | 426 | 426 | 260 | 104 | 107 | 82 |
% in Category | 38 | 38 | 27 | 23 | 23 | 26 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Legal General US Index Trust F Acc | 765.76K | 10.67 | 13.38 | 15.24 | ||
Legal General US Index Trust F Dist | 20.51K | 10.62 | 13.37 | 15.23 | ||
Legal General US Index Trust C Acc | 3.59B | 7.11 | 14.19 | 15.31 | ||
Legal General US Index Trust C Dist | 953.78M | 7.07 | 14.19 | 15.30 | ||
Legal General US Index Trust I Acc | 1.41B | 7.04 | 14.13 | 15.25 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund U G | 3.91B | 7.74 | 9.50 | 13.38 | ||
Wellington Global Health Care EquiG | 2.5B | 5.25 | 5.27 | 13.12 | ||
Global Health Care Fund W Acc GBP | 114.33M | -8.92 | 12.63 | 14.43 | ||
Adamant Medtech I GBP | 1.52B | 10.64 | 6.33 | 14.31 | ||
Pharmaceuticals Index Trust F Dist | 877.57Array | 8.28 | 10.01 | 11.73 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.26 | 735.54 | -2.69% | |
UnitedHealth | US91324P1021 | 6.04 | 492.66 | -0.06% | |
J&J | US4781601046 | 5.07 | 149.26 | -0.44% | |
Novo Nordisk B | DK0062498333 | 4.89 | 850.6 | -2.58% | |
Merck&Co | US58933Y1055 | 4.23 | 127.52 | -0.58% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Strong Buy |
Technical Indicators | BUY | BUY | Strong Buy |
Summary | Buy | Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review